VistaGen Therapeutics (VTGN) reported Q2 revenue

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to VistaGen Therapeutics (VTGN) reported Q2 revenue
(NASDAQ: VTGN) Delayed: 0.64 -0.03 (4.48%)
Previous Close $0.67    52 Week High $4.60 
Open $0.71    52 Week Low $2.81 
Day High $0.71    P/E N/A 
Day Low $0.62    EPS $0.00 
Volume 1,204,131